
Technology change in life sciences carries an obligation that most sectors do not share: you must be able to demonstrate, afterwards and to someone else’s satisfaction, that the system does what you said it does and that the data it holds can be trusted.
Teams coming from less regulated environments tend to treat this as a validation exercise appended to delivery. Teams who have worked in GxP environments know it shapes the delivery approach from the first design conversation, and that discovering this late is what turns a six-month project into an eighteen-month one.
Quality is a design participant
The most common structural mistake is sequential: business defines requirements, technology builds, quality reviews. By the time quality sees it, decisions are embedded that are expensive to revisit — how audit trails are captured, how electronic signatures are handled, how a record’s history is reconstructed.
Bringing quality into design conversations is not about adding approval steps. It is about surfacing constraints while they are still cheap to accommodate. A well-posed question in week two — what evidence will we need that this calculation is correct, and how will we produce it in three years? — prevents a rebuild in month nine.
Data integrity is an architectural property
The ALCOA+ principles — attributable, legible, contemporaneous, original, accurate, and the rest — read like documentation guidance. They are really architectural requirements.
Attributable means the system must know who did what, including through integrations and automated processes. Contemporaneous means capture at the time of the activity, which constrains batch patterns. Original means the authoritative record is identifiable when the same data exists in several systems.
Designed in, these are unremarkable. Retrofitted, they are among the harder things to add to a working system, because they touch how every record is created and stored.
Scope validation to risk
Validation effort should follow patient safety, product quality and data integrity risk. Applying uniform rigour everywhere is expensive and, more damagingly, it trains the organisation to treat validation as paperwork — which is precisely when it stops catching real problems.
A risk-based approach requires a defensible rationale for where effort is concentrated. That rationale is worth writing down early, because it is the thing an inspector will want to understand, and because it lets teams move quickly on the parts that genuinely warrant it.
Change control decides your delivery cadence
Iterative delivery and formal change control are not incompatible, but they have to be designed to fit. The question is what constitutes a change requiring assessment, what can be handled under an approved procedure, and how quickly assessments actually happen.
An organisation that can assess a low-risk change in days can work iteratively. One where every change takes six weeks will deliver in large infrequent releases whatever its stated methodology — and large infrequent releases carry more risk, not less, which is the irony of the arrangement.
Adoption in validated environments
A validated system that people work around is a compliance risk, not just a wasted investment — because the real process is now the undocumented one. Where people keep a parallel spreadsheet, that spreadsheet is part of your process whether or not anyone has acknowledged it.
So adoption deserves the same seriousness as validation. If the compliant path is slower than the workaround, the workaround will win, and no amount of training will change that.
What to establish before building
Before significant build effort: who owns the process, not just the system; what the validation approach is and why; how data will be attributed and retained; what evidence will be produced and by whom; and how changes will be assessed once live.
None of that is technology work. All of it determines how long the technology work takes — and in regulated environments, the projects that run smoothly are almost always the ones that settled these questions before the first sprint rather than during the third.
